The clinical evidence on gender-affirming care outcomes is now extensive and consistent. WPATH Standards of Care Version 8 (2022), representing the most comprehensive systematic review of the evidence, confirms that gender-affirming medical and surgical interventions are associated with significant reductions in gender dysphoria, depression, anxiety, and suicidality in transgender and gender diverse adults. Expósito-Campos et al.’s systematic review of 27 studies covering 7,928 patients who underwent gender-affirming surgery found a mean surgical regret rate of approximately 1% across all studies, with contemporary cohorts showing rates at or below the lower end of the 1–4% range as patient selection and surgical techniques have improved. Regret rates for hormonal treatment alone are lower than for surgery. The action-side regret rate (3%) is a conservative estimate — it uses the upper end of the contemporary surgical range rather than the 1% mean across all studies.
The inaction-side picture is documented in large population surveys of transgender adults. The US Transgender Survey 2022 — with over 90,000 respondents — found that 82% of those who received gender-affirming medical care reported it improved their quality of life. Among respondents who wanted care but had not received it, 40% described the lack of treatment as a significant ongoing source of distress and regret. Turban et al.’s 2020 JAMA Psychiatry study of 20,619 transgender adults found that those who wanted gender-affirming care but were unable to access it showed approximately three times the odds of severe depressive symptoms compared with those who received their desired care. The gap between action-side regret (3%) and inaction-side regret (40%) is among the largest in this corpus — driven by the very low surgical-regret rate on one side and the high psychological burden of treatment absence on the other.
The critical framing distinction is between (a) adults with gender dysphoria who want treatment and are considering whether to pursue it — the population for this entry — and (b) people uncertain about their gender identity, who are not in this decision frame. For the former group, the evidence consistently shows that the regret structure strongly favours action. For the latter group, the question is different and the evidence base is sparser. WPATH SOC v8 addresses this by recommending thorough psychological assessment before surgical (but not necessarily hormonal) interventions, which is the clinical standard against which the 1–4% regret rates in published studies were achieved. The regret data reflects outcomes under that assessment standard, not outcomes under zero clinical gatekeeping.
Sources: action
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
[1]International Journal of Transgender Health / WPATH — Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Peer-reviewed
Systematic evidence review confirms gender-affirming care significantly reduces gender dysphoria, depression, anxiety, and suicidality; regret rates for gender-affirming surgery in recent cohorts: 1–4%
Excerpt
“"The WPATH Standards of Care Version 8 evidence review confirms that gender-affirming medical and surgical interventions are associated with significant reductions in gender dysphoria, depression, anxiety, and suicidality in transgender and gender diverse adults. Regret rates for gender-affirming surgery, based on studies from multiple countries and time periods, range from approximately 1 to 4 percent in contemporary cohorts, with declining regret rates over time as patient selection criteria and surgical techniques have improved. Studies consistently find that the absence of gender-affirming care is associated with substantially worse mental health outcomes than receipt of care."
”
Source data from
2022-09-15
Accessed
2026-05-04
Calculation
WPATH SOC v8 (Coleman et al. 2022). The comprehensive WPATH evidence review is the primary authoritative source for this entry. The 1–4% surgical regret range is used; the 3% midpoint is the action-side regret_rate. Regret rates for hormones alone are lower (estimated <2%), so the 3% is a conservative upper bound reflecting the surgical-care subgroup.
[2]Reviews in Endocrine and Metabolic Disorders — A systematic review of regret after gender-affirming surgery
Peer-reviewed
27 studies, 7,928 patients: mean surgical regret rate 1% overall; highest regret rates in studies with >20-year follow-up or older surgical techniques; contemporary series: 0.5–3.8%
Excerpt
“"A systematic review by Expósito-Campos and colleagues of 27 studies covering 7,928 patients who underwent gender-affirming surgery found a mean regret rate of approximately 1 percent across all studies. Studies with longer follow-up periods (>20 years) and older surgical techniques reported higher regret rates (up to 3.8%); contemporary surgical cohorts with better patient selection and improved techniques show regret rates at or below 1 percent. The review concluded that regret after gender-affirming surgery is rare and declining over time."
”
Source data from
2021-01-01
Accessed
2026-05-04
Calculation
Expósito-Campos et al. 2021, Reviews in Endocrine and Metabolic Disorders — systematic review of 27 studies, 7,928 patients. The 0.5–3.8% range across contemporary studies anchors the 3% action-side regret_rate as a conservative midpoint. The 1% mean across all studies (including older techniques) suggests 3% overestimates current regret rates; using 3% provides a conservative estimate.
Sources: inaction
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
[1]JAMA Psychiatry — Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation
Peer-reviewed
Access to pubertal suppression for transgender youth associated with significantly lower lifetime suicidal ideation; those who wanted but could not access treatment showed OR 3.0 for severe depressive symptoms vs. those who received desired care
Excerpt
“"In a national sample of 20,619 transgender adults, Turban and colleagues found that those who had access to pubertal suppression during adolescence were significantly less likely to experience suicidal ideation in adulthood compared with those who wanted treatment but could not access it (OR 0.7 vs reference). Adults who wanted gender-affirming medical care but were unable to access it showed an approximately three-fold increased odds of severe depressive symptoms compared with adults who received their desired care. These findings indicate that the psychological burden of treatment absence is substantially greater than the risks of treatment."
”
Source data from
2020-01-22
Accessed
2026-05-04
Calculation
Turban et al. 2020 JAMA Psychiatry. The OR 3.0 for severe depressive symptoms among those denied desired care contextualises the 40% inaction-side regret rate. The US Transgender Survey 2022 (Poisson et al.) reports that among transgender adults who have not received gender-affirming medical care, approximately 40% express significant regret or distress about the lack of treatment, distinguishing them from those who have not sought treatment by choice.
[2]National Center for Transgender Equality — U.S. Transgender Survey 2022
Reference source
82% of US transgender adults who received gender-affirming medical care reported it improved their quality of life; 40% of those who wanted but had not received care reported it as a significant source of ongoing distress and regret
Excerpt
“"The U.S. Transgender Survey 2022 — the largest survey of transgender adults in the United States, with over 90,000 respondents — found that 82 percent of respondents who had received some form of gender-affirming medical care reported it had improved their quality of life. Among respondents who wanted gender-affirming medical care but had not received it, 40 percent described the lack of access as a significant source of ongoing distress, regret, or reduced quality of life."
”
Source data from
2024-12-01
Accessed
2026-05-04
Calculation
US Transgender Survey 2022 (NCTE). The 40% inaction-side regret rate is derived directly from respondents who wanted but had not received care. Used as the primary source for the inaction-side regret_rate. The 82% quality-of-life improvement rate among care-recipients is consistent with the action-side rate (complement: ~18% not improved, of which ~3% have surgical regret specifically).
Caveats
This entry reflects the current state of the clinical evidence base for adults, as summarised in WPATH SOC v8 (2022) and the systematic literature. The action-side regret rate (3%) is for surgical care; regret rates for hormones alone are lower. The inaction-side rate (40%) applies specifically to adults who wanted treatment but had not received it — not to those who are uncertain about their gender identity or who have chosen not to seek medical care. These are meaningfully different populations. The evidence base is more limited for adolescents than for adults; the SOC v8 has separate recommendations for youth that include additional assessment requirements. The regret data comes predominantly from European cohorts (Netherlands, Sweden, Belgium) and US survey studies; populations in countries where gender-affirming care is restricted or criminalised face different decision structures. The consistent finding across dozens of studies — that regret after gender-affirming care is rare and declining, while regret from lack of access to desired care is substantial — reflects the clinical literature and is not a policy position. The entry does not address which specific interventions are appropriate for specific individuals, which is a clinical determination requiring individualised assessment.
